Stocks · Health care · Biological Products, (No Diagnostic Substances)

Denali Therapeutics Inc.

DNLI Clue Score33
United States Fiscal year ends December CIK 0001714899 Results filed 3 Nov 2026

What the insiders did Net selling

By person

22 insiders · 516 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Douglas K Bratton
10% owner
$4.95M (1)
$335.63M (19)
−$330.68M
9,984,836
6.25%
$222.56M
+3,095%
Ryan J. Watts
President and CEO
—
$41.18M (122)
−$41.18M
2,417,217
1.51%
$53.88M
−19.2%
Marc Tessier-Lavigne
Director
—
$36.20M (40)
−$36.20M
1,965,424
1.23%
$43.81M
−28.8%
Alexander O. Schuth
COFO and Secretary
—
$18.46M (121)
−$18.46M
1,342,051
0.8396%
$29.91M
+1.1%
Steve E. Krognes
Director
—
$15.19M (37)
−$15.19M
888,202
0.5557%
$19.80M
+41.2%
Carole Ho
Chief Medical Officer
—
$11.29M (101) scheduled
−$11.29M
415,362
0.2598%
$9.26M
−5.8%
David P Schenkein
Director
—
$7.84M (7)
−$7.84M
47,897
0.0300%
$1.07M
—
Vicki L Sato
Director
—
$1.78M (50)
−$1.78M
107,976
0.0675%
$2.41M
+38.0%
Nancy Thornberry
Director
—
$261.93K (2) scheduled
−$261.93K
19,686
0.0123%
$438.80K
+944.9%
Peter Scott Chin
Chief Medical Officer
—
$36.87K (1)
−$36.87K
204,538
0.1280%
$4.56M
−0.8%
Jennifer E. Cook
Director
—
$31.68K (1) scheduled
−$31.68K
32,483
0.0203%
$724.05K
—
ARCH Venture Fund VIII, L.P. entity
10% owner
—
—
—
10,668,749
6.67%
$237.81M
+3,314%
Robert Nelsen
Director
—
—
—
9,681,181
6.06%
$215.79M
+2,998%
Flagship Ventures Fund V, L.P. entity
10% owner
—
—
—
8,918,749
5.58%
$198.80M
+2,754%
Baker Bros. Advisors LP entity
Director
—
—
—
3,422,366
2.14%
$76.28M
+1.0%
FIL Ltd entity
See Remark 1
—
—
—
1,916,212
1.20%
$42.71M
—
Jay T Flatley
Director
—
—
—
363,157
0.2272%
$8.09M
+358.4%
Peter S Klein
Director
—
—
—
33,941
0.0212%
$756.54K
—
Fmr LLC entity
See Remark 1
—
—
—
33,215
0.0208%
$740.36K
—
Douglas G. Cole
Director
—
—
—
26,564
0.0166%
$592.11K
+140.7%
Erik Harris
Director
—
—
—
17,052
0.0107%
$380.09K
—
Hauwermeiren Timothy Van
Director
—
—
—
17,040
0.0107%
$379.82K
—